4 completed, 1 not yet recruiting. 5 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Not yet recruiting 1 |
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Acute Myeloblastic Leukemia: new trials by email Literature Review of Acute Myeloblastic Leukemia trials Research Report on Acute Myeloblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Palbociclib, All-Trans Retinoic Acid, and Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia Palbociclib, All-trans retinoic acid, Venetoclax - Acute Myeloblastic Leukemia | Phase 1 / Phase 2 | Not yet recruiting | Second Affiliated Hospital of Nanchang University | 55 | 2026-11-01 | 2026-11-09 |
| Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia fludarabine, Idarubicin, cytarabine - Acute Myeloblastic Leukemia | Phase 1 / Phase 2 | Completed | PETHEMA Foundation | 55 | 2012-07-01 | 2017-04-25 |
| Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia sodium chloride solution 0.9%, temsirolimus - Acute Myeloblastic Leukemia | Phase 2 | Completed | Goethe University | 33 | 2012-05-01 | 2023-05-24 |
| Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen Clofarabine/Busulfan x 4, Peripheral blood stem cell transplant - Acute Myeloblastic Leukemia | Phase 2 | Completed | University of Michigan Rogel Cancer Center | 75 | 2011-11-01 | 2017-06-02 |
| Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant Alentuzumab, Globulina antilinfocitaria - Acute Myeloblastic Leukemia, Lymphoblastic Leukemia | Phase 2 / Phase 3 | Completed | Gruppo Italiano Trapianto di Midollo Osseo | 121 | 2005-03-01 | 2023-03-10 |
Leukemia, Myeloid, Acute (5) · Anemia, Refractory, with Excess of Blasts (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Primary Myelofibrosis (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Leukemia (5) · Leukemia, Myeloid (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Anemia (1) · Anemia, Refractory (1) · Bone Marrow Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1)
Clofarabine (1) · Cytarabine (1) · Granulocyte Colony-Stimulating Factor (1) · Idarubicin (1) · Peripheral Blood Stem Cell Transplantation (1) · Tretinoin (1) · fludarabine (1) · palbociclib (1) · plerixafor (1) · temsirolimus (1) · venetoclax (1)
Goethe University (1) · Gruppo Italiano Trapianto di Midollo Osseo (1) · PETHEMA Foundation (1) · Second Affiliated Hospital of Nanchang University (1) · University of Michigan Rogel Cancer Center (1)
Canada (1) · China (1) · Germany (1) · Italy (1) · Spain (1) · United States (1)
Alessandro Rambaldi, MD (1) · Christian Brandts, MD (1) · John M Magenau, MD (1) · Shin Mineishi, MD (1) · Stephen J Forman, MD (1)